Maiwald Patentanwalts competitive analysis

Explore patent oppositions filed by Maiwald Patentanwalts against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Aug 20, 2026
Patent NumberTitleApplicantOpposition Date
Antibody-Containing PreparationCHUGAI SEIYAKU KABUSHIKI KAISHAAug 7, 2026
Methods For Purification Of Messenger RnaTRANSLATE BIOAug 5, 2026
Methods Of Treating Fabry Disease In Patients Having A Mutation In The Gla GeneAMICUS THERAPEUTICSAug 4, 2026
Method Of Treating Cancer Using Immune Checkpoint Inhibitor; Antibody That Binds To Programmed Death-1 Receptor (Pd-1) Or Programmed Death Ligand 1 (Pd-L1)BRISTOL MYERS SQUIBBJul 28, 2026
Drug Delivery DeviceAMGENJun 3, 2026
Migalastat Formulations Having Improved PharmacokineticsAMICUS THERAPEUTICSJun 1, 2026
Ophthalmic Composition Based On Hyaluronic Acid To Protect From Damages Caused By Environmental PollutionCOLOMBOMay 12, 2026
A Novel Method For Stabilization Of A Biopharmaceutical Drug Product During ProcessingLEUKOCAREMay 5, 2026
Methods Of Treating Fabry Patients Having Renal ImpairmentAMICUS THERAPEUTICSApr 15, 2026
Use Of Long-Acting Glp-1 PeptidesNOVO NORDISKApr 9, 2026

Latest PTAB cases involving Maiwald Patentanwalts

Discover the latest PTAB cases involving Maiwald Patentanwalts, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Maiwald Patentanwalts with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Aug 20, 2026
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
MAIWALD PATENTANWALTS159 - - -
AKZO NOBEL COATINGS INTERNATIONAL BV4633 - -
NOVOZYMES4839 - 3